Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 2.19M | $61.3M | $28.04 | Jun 13, 2023 | Direct |
Trevi Therapeutics, Inc. | 10%+ Owner | Common Stock | 10.4M | $21.1M | $2.02 | Apr 11, 2022 | Direct |
Metacrine, Inc. | 10%+ Owner | Common Stock | 2.56M | $1.2M | $0.47 | Dec 22, 2021 | Direct |
NeueHealth, Inc. | 10%+ Owner | Warrant (Right to Buy) | 186K | Oct 1, 2024 | Direct | ||
Akouos, Inc. | 10%+ Owner | Common Stock | 0 | $12.50 | Nov 30, 2022 | Direct | |
GENOCEA BIOSCIENCES, INC. | 10%+ Owner | Common Stock | 0 | $1.25 | May 25, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NEUE | NeueHealth, Inc. | Oct 1, 2024 | 1 | $0 | 4 | Oct 3, 2024 | 10%+ Owner |
NEUE | NeueHealth, Inc. | Apr 8, 2024 | 1 | $0 | 4 | Apr 10, 2024 | 10%+ Owner |
MIRM | Mirum Pharmaceuticals, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | 10%+ Owner |
AKUS | Akouos, Inc. | Nov 30, 2022 | 1 | $0 | 4 | Dec 2, 2022 | 10%+ Owner |
GNCA | GENOCEA BIOSCIENCES, INC. | May 24, 2022 | 2 | -$751K | 4 | May 26, 2022 | 10%+ Owner |
TRVI | Trevi Therapeutics, Inc. | Apr 11, 2022 | 1 | $5M | 4 | Apr 13, 2022 | 10%+ Owner |
MTCR | Metacrine, Inc. | Dec 10, 2021 | 3 | -$494K | 4 | Dec 27, 2021 | 10%+ Owner |
TRVI | Trevi Therapeutics, Inc. | Oct 18, 2021 | 3 | $0 | 4 | Oct 19, 2021 | 10%+ Owner |